Unlike mTORC1, mTORC2 is less nutrient-sensitive and is instead heavily modulated by growth factors
As GLP-1 patents expire and Indian pharma giants launch generic versions, treatments once reserved for the affluent could become accessible to millions
All State and Union Territory drug controllers have also been asked to actively monitor print, electronic, digital, social-media, and outdoor platforms for non-compliant advertisements or surrogate promotional activities relating to these drugs
Label reconstituted samples clearly with preparation date and concentration
Patentability and Funding: The commercial development of BPC-157 will also depend on navigating patent landscapes
Safety, tolerability, pharmacokinetics, and clinical outcomes following treatment of painful knee osteoarthritis with senolytic molecule UBX0101